Piglets that are not actively massaging the udder and thereby stimulating the release of prolactin leads to:
Premature cessation of milk production
Irregular return to oestrus
Strong, active piglets will stimulate the sow to produce the maximum amount of milk.
Oral application of an anti-inflammatory agent: Less stress and improved animal welfare
Research at the LfULG Kollitsch showed:
Anti-inflammatory agents, when applied orally and at the right moment will result in
Lower (normal) body-temperature of the sow
Better feed-intake of the sow
7 % less pre-weaning losses and higher weaning weights
Ingelheim, Germany, 26 September 2016 - Veterinarians and farmers across the globe have reached the landmark of protecting one billion sows and pigs against the potentially devastating effects of Porcine Reproductive and Respiratory Syndrome (PRRS) using Ingelvac PRRS MLV ®. The vaccine, which was launched in 1994 in the USA, is currently marketed in 19 countries in Asia, Europe, and North America. It contributes to securing the pigs’ health as well as providing healthy pork for consumers around the world.
US - Boehringer Ingelheim Vetmedica, Inc has launched two initiatives on Porcine Epidemic Diarrhoea (PED) for swine industry; it has announced applied research funding and a PED News service for vets.
Boehringer Ingelheim Animal Health has decided to remain focused on freshly mixed Porcine Circovirus type 2 (PCV2)/ Mycoplasma hyopneumoniae (M.hyo) vaccines and not follow the development of a PCV2/M.hyo ready-to-use (RTU) vaccine combination. As a consequence of this decision, the company has discontinued its PCV2/M.hyo RTU research program.
Get the latest news on Swine Health Subscribe to our newsletter